NCT04163107 2022-03-18
MYELOMA-HCQ
Norwegian University of Science and Technology
Phase 1 Completed
Clinical Trials
4 trialsNCT00568880 2020-02-07
Hydroxychloroquine and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
Abramson Cancer Center at Penn Medicine
Phase 1 Completed
NCT01689987 2017-09-07
Hydroxychloroquine, Cyclophosphamide, Dexamethasone, and Sirolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma
OHSU Knight Cancer Institute
Phase 1 Completed
NCT01396200 2013-02-26
Cyclophosphamide and Pulse Dexamethasone With Rapamycin or Hydroxychloroquine
Abramson Cancer Center at Penn Medicine
Phase EARLY_PHASE1 Completed